Substance abuse in the United States is one of the leading health conditions impacting millions of lives and due to many types of drug addictions. Since 2000, there have been 700,000 overdose deaths ...

This training course will guide you through the principles of safe prescribing and demonstrate how to complete the National Standard Medication Charts correctly. The course comprises of 5 modules: ...

A recent survey reveals a significant decline in teen drug and alcohol use since 2017, reaching its lowest point in 2024. Researchers attribute this drop to pandemic lockdowns disrupting social ...

The correct dosage of diphenhydramine for dogs depends ... there are some alternatives you can use. Both cetirizine (Zyrtec) and loratadine (Claritin) are considered safe for dogs in the right ...

Medications belonging to this family of drugs include: Oxybutynin: Available in tablet form (under its generic name) and transdermal patch (under brand name Oxytrol) Tolterodine: Available in tablet ...

Newer PCSK9 inhibitor drugs can drop levels even further. Someone in the United States dies from heart disease every 33 seconds. It remains the number one killer in the country. So it’s no ...

21, 2024 Amanda Vlakos had been living for years in rat-infested abandoned buildings in Baltimore, fighting an addiction to opioids, when she learned of a possible escape: a drug-treatment program ...

From 2017 to 2020, it increased to 41.9%. Prescription weight loss medication has become extremely popular because it is easy to take and effective. But, it is expensive, and people must also try ...

Teen drug use continued to fall in 2024, extending a dramatic decline spurred by the COVID-19 pandemic that experts expected would reverse now that the acute phase of the global crisis is well over.

LONDON, Dec 17 (Reuters) - A new long-acting preventive HIV drug could reach the world’s poorest countries by the end of 2025 or early 2026, a global health official told Reuters on Tuesday.

Dec 16 (Reuters) - Merck (MRK.N), opens new tab said on Monday it has discontinued the development of two experimental cancer drugs after their failure in several trials. The pharmaceutical giant ...